title: Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy.
abstract: Peak VO(2) and the Heart Failure Survival Score are 2 clinical parameters used to risk stratify patients with heart failure and time listing for cardiac transplantation. The efficacy of these prognostic variables in patients receiving beta-blocker therapy was evaluated.
authors.affiliation: Department of Medicine, Columbia University, New York, New York, USA.
authors.forename: Lars H
authors.initials: LH
authors.lastname: Lund
authors.forename: Keith D
authors.initials: KD
authors.lastname: Aaronson
authors.forename: Donna M
authors.initials: DM
authors.lastname: Mancini
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000502:physiology; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis
chemical_list: D000319:Adrenergic beta-Antagonists